CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 2. PMA-mediated signaling in PMA-resistant K562 cells. The effect of PMA treatment on signal transduction pathways in both wild-type and PMA-resistant K562 cells was studied by measuring the levels of PKC (A) or Pyk2 (B) or the activation of the MAPK pathway (C and D). Data presented in D depict the C1 clone. Samples were processed as described in "Materials and Methods."





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation